Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
547.16 USD | -0.71% | +0.01% | +3.20% |
12-01 | U.S. Currency | FA |
11-30 | Explainer-Why prior mega health insurer deals like the possible Cigna/Humana merger failed | RE |
Sales 2023 * | 369 B 498 B | Sales 2024 * | 397 B 536 B | Capitalization | 506 B 683 B |
---|---|---|---|---|---|
Net income 2023 * | 22.21 B 29.97 B | Net income 2024 * | 24.73 B 33.38 B | EV / Sales 2023 * | 1,45x |
Net Debt 2023 * | 27.19 B 36.69 B | Net Debt 2024 * | 18.13 B 24.47 B | EV / Sales 2024 * | 1,32x |
P/E ratio 2023 * | 23,0x | P/E ratio 2024 * | 20,5x | Employees | 400,000 |
Yield 2023 * | 1,32% | Yield 2024 * | 1,46% | Free-Float | 99.72% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | -0.71% | ||
1 week | +0.01% | ||
Current month | -1.05% | ||
1 month | +2.93% | ||
3 months | +14.89% | ||
6 months | +10.84% | ||
Current year | +3.20% |
1 week
528.65
554.70

1 month
528.34
554.70

Current year
445.68
554.70

1 year
445.68
554.70

3 years
320.35
558.10

5 years
187.72
558.10

10 years
69.57
558.10

Managers | Title | Age | Since |
---|---|---|---|
Andrew Witty
CEO | Chief Executive Officer | 58 | 2017 |
Dirk McMahon
PSD | President | 63 | 2002 |
Director of Finance/CFO | - | 2006 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Flynn
BRD | Director/Board Member | 66 | 2017 |
Michele Hooper
BRD | Director/Board Member | 71 | 2006 |
Stephen Hemsley
CHM | Chairman | 70 | 1997 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
22.64% | 821 M€ | -3.96% | - | |
15.70% | 4 M€ | +15.01% | - | |
13.65% | 26 M€ | +9.77% | - | |
11.30% | 101 M€ | +20.98% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 547.16 | -1.05% | 3,461,900 |
23-11-30 | 552.97 | +3.36% | 7,121,207 |
23-11-29 | 534.98 | -1.03% | 4,549,977 |
23-11-28 | 540.53 | -0.56% | 2,859,309 |
23-11-27 | 543.59 | -0.64% | 2,675,815 |
Delayed Quote Nyse, December 01, 2023 at 04:00 pm
More quotes
UnitedHealth Group Inc. is one of the leading American suppliers of healthcare products and services. Income breaks down by activity as follows:
- health insurance (57.4%; UnitedHealthcare);
- prescription insurance plan management services (39.3%; Optum Health and Optum Rx): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- provision of computer services (3.3%; Optum Insight): consulting, development, and integration of solutions for transaction management, healthcare plan management, data processing, etc.
Sector
Managed Healthcare
Calendar
2024-01-15
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
BUY
Number of Analysts
25
Last Close Price
547.16USD
Average target price
587.61USD
Spread / Average Target
+7.39%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.20% | 511 B $ | |
-18.81% | 76 924 M $ | |
-3.32% | 59 691 M $ | |
-8.69% | 39 360 M $ | |
+9.85% | 21 312 M $ | |
+11.04% | 3 293 M $ | |
-37.41% | 1 418 M $ | |
+2.21% | 449 M $ |

MarketScreener is also available in United States.
Switch edition
Stay in the current country edition